380 related articles for article (PubMed ID: 10173273)
1. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
Marthaler AL
Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273
[No Abstract] [Full Text] [Related]
2. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
Struve CT
Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
[No Abstract] [Full Text] [Related]
3. Legal overprotection.
Friedman JH
Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378
[No Abstract] [Full Text] [Related]
4. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
O'Reilly JT
Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
[No Abstract] [Full Text] [Related]
5. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
Jarcho DG
Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730
[No Abstract] [Full Text] [Related]
6. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
Leghorn J; Brophy E; Rother P
Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
[No Abstract] [Full Text] [Related]
7. Medical device preemption after Medtronic, Inc. v. Lohr.
Neraas MB
Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731
[No Abstract] [Full Text] [Related]
8. License to maim: federal pre-emption and the Medical Device Amendments of 1976.
Petrella ME
Health Matrix Clevel; 1996; 6(2):349-89. PubMed ID: 10178392
[No Abstract] [Full Text] [Related]
9. The FDA, preemption, and the Supreme Court.
Glantz LH; Annas GJ
N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
[No Abstract] [Full Text] [Related]
10. The Canadian perspective: trends in drug and medical device class actions in Canada.
Vernon W
Food Drug Law J; 2006; 61(3):569-76. PubMed ID: 16989040
[No Abstract] [Full Text] [Related]
11. The impact of FDA reform.
Trunzo J
Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
[TBL] [Abstract][Full Text] [Related]
12. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
13. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
Lang L
Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
[No Abstract] [Full Text] [Related]
14. Injured consumers and the FDA. Should federal preemption protect medical device manufacturers under a quasi-governmental immunity?
Truitt BI
J Leg Med; 1994 Mar; 15(1):155-84. PubMed ID: 8201276
[No Abstract] [Full Text] [Related]
15. Ejecting the FDA from the courtroom.
Lancet; 2004 Aug 21-27; 364(9435):638. PubMed ID: 15325808
[No Abstract] [Full Text] [Related]
16. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
[TBL] [Abstract][Full Text] [Related]
17. Federal pre-emption under the Food, Drug & Cosmetic Act from Medtronic, Inc. v. Lohr; Pliva. Inc. v. Mensing.
Ball FR
Health Care Law Mon; 2011 Sep; 2011(9):2-8. PubMed ID: 21949984
[No Abstract] [Full Text] [Related]
18. The Supreme Court, preemption, and malpractice liability.
Kesselheim AS; Studdert DM
N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
[No Abstract] [Full Text] [Related]
19. Pedicle screws. Lack of FDA approval does not implicate use in hospital.
West JC
J Healthc Risk Manag; 1998; 18(2):53-5. PubMed ID: 10185080
[No Abstract] [Full Text] [Related]
20. The preemptive scope of the Medical Device Amendments of 1976.
Sunshine PH
Food Drug Law J; 1995; 50(1):191-212. PubMed ID: 10342991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
